Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,194.7
20.5 (0.65%)

 

  • STI Straits Times Index
    3,194.7
    20.5 (0.65%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,568.4
    4.9 (0.31%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,498.4
    281.3 (1.07%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,912.0
    12.5 (0.43%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    23,354.4
    54.3 (0.23%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,186.9
    34.8 (0.56%)
    Index delayed 10 minutes
  • KOR KOSPI
    2,081.8
    21.1 (1.02%)
    Index delayed 20 minutes
  • XAO XAO
    6,813.5
    22.4 (0.33%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 718.9M
  • Value: 1,161.4M
  • Rise: 142
  • Fall: 133
  • Unch: 551

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Golden Agri-Res0.220-0.010
YZJ Shipbldg SGD1.110+0.010
Rex Intl0.169-0.005
Tritech0.024-0.002
SingTel3.430+0.020
OCBC Bank10.710+0.060
Genting Sing0.920+0.005
Mapletree Log Tr1.740+0.020
Mapletree NAC Tr1.180+0.030
ThaiBev0.900+0.005

World Indices

World Indices
Name Last Change
Nasdaq 8,656.5 +85.8
HSI 26,498.4 +281.3
HSCEI 10,407.2 +85.3
Jakarta 6,186.9 +34.8
Nikkei 225 23,354.4 +54.3
SSE Comp 2,912.0 +12.6
Shanghai A 3,051.3 +13.1
Shanghai B 243.4 +1.8
PSE Comp 0.0
KOSPI 2,081.8 +21.1

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

MYOVANT SCIENCES LTD MYOVANT SCIENCES LTD.
Updated on 05 Dec 2019 (End of trading day)
Last (USD): 16.780 Change: -0.540 High: 17.920 Remarks: -
Change (%): -3.12 Low: 16.630
Open 17.520 Yesterday's Close 17.32
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 1,690,598 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -3.05221 Trailing EPS (USD) e -3.17012 NAV (USD) b 0.1925
PE a - Trailing PE f - Price / NAV b 87.1688
Dividend (USD) d - Cash In Hand (USD) g 1.4547 Issued & Paid-up Shares c 89,624,000
Dividend Yield (%) d - Price / Cash In Hand g 11.535 Treasury Shares h -
Beta - 75 Daysi -0.182 R-Squared - 75 Days(%)i 0.08 Market Cap (M) 1,503.891
Beta - 500 Daysi 0.232 R-Squared - 500 Days (%)i 0.26 Enterprise Value (M) 1,456.948
Piotroski F Score 0 Exchange Code MYOV Par Value ( $ ) n.a.
52 Weeks Volatility (%) 111.98 Free Float (%) 36.0
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 13 Nov 2019.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 24 Oct 2016.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference MYOVANT SCIENCES LTD NYSE 1,503.891 - - 87.1688 -
Industry Biotechnology NYSE 5,097.771 17173.851 49.329 5.0128 0.620
Local Peer AGILENT TECHNOLOGIES INC NYSE 25,230.926 79.844 23.558 5.3140 0.751
Local Peer EMERGENT BIOSOLUTIONS INC NYSE 2,714.390 43.292 631.253 2.6226 -
Local Peer KADMON HLDGS INC NYSE 652.727 - - 17.0844 -
Local Peer ARCUS BIOSCIENCES INC NYSE 357.242 - - 2.0157 -
Local Peer ENZO BIOCHEM INC NYSE 127.453 51.204 51.206 1.4816 -
Global Peer AMGEN INC NASDAQ 138,902.394 16.548 17.219 12.7119 2.393
Global Peer CSL ASX 127,536.908 47.537 47.537 17.0432 0.944
Global Peer GILEAD SCIENCES INC NASDAQ 84,866.262 15.558 31.514 4.1189 3.444
Global Peer AMGEN-T HKEx 594,184.000 9.032 9.399 6.9364 4.385
Global Peer VERTEX PHARMACEUTICAL NASDAQ 57,408.738 27.385 26.779 10.9279 -
Global Peer BIOGEN INC NASDAQ 54,179.515 12.228 10.041 3.8711 -
Global Peer ILLUMINA INC NASDAQ 47,991.090 58.101 49.323 10.8112 -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 40,872.648 16.721 19.062 3.8910 -
Global Peer ALEXION PHARMACEUTICAL INC NASDAQ 25,202.832 324.778 17.141 2.4310 -
Global Peer INCYTE CORPORATION NASDAQ 20,350.709 185.864 50.253 8.4006 -
Other Global Peers SEATTLE GENETICS INC (NASDAQ), SINO BIOPHARM (HKEx), WUXI BIO (HKEx), BIOMARIN PHARMACEUTICAL (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), EXACT SCIENCES CORP (NASDAQ), BEIGENE (HKEx), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), MODERNA INC (NASDAQ), 10X GENOMICS INC (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), EXELIXIS INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), GENSCRIPT BIO (HKEx), REPLIGEN CORP (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), Lonza (SGX), CRISPR THERAPEUTICS AG (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), SPARK THERAPEUTICS INC (NASDAQ), FIBROGEN INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), IMMUNOMEDICS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), 3SBIO (HKEx), NEKTAR THERAPEUTICS (NASDAQ), ALKERMES PLC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), NATERA INC (NASDAQ), UNIQURE N.V. (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), AUDENTES THERAPEUTICS INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), XENCOR INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), INSMED INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), HAOHAI BIOTEC (HKEx), EPIZYME INC (NASDAQ), REGENXBIO INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), ARVINAS INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), VERACYTE INC (NASDAQ), VIELA BIO INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), ALECTOR INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), NEXTCURE INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), OPKO HEALTH INC (NASDAQ), FRONTAGE (HKEx), FATE THERAPEUTICS (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), CKLIFE SCIENCES (HKEx), VANDA PHARMACE INC (NASDAQ), VIVA BIOTECH (HKEx), AVITA MEDICAL LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), AVITA MEDICAL LTD (ASX), ASCENTAGE-B (HKEx), INTREXON CORP (NASDAQ), ACHILLION PHARMACEUTICALS INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), SYNTHORX INC (NASDAQ), POLYNOVO LIMITED (ASX), HOMOLOGY MEDICINES INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), CORTEXYME INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), TG THERAPEUTICS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), MESOBLAST LTD (ASX), UROGEN PHARMA LTD (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), OMEROS CORP (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), TRANSLATE BIO INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), IMMUNOGEN INC (NASDAQ), RETROPHIN INC (NASDAQ), AVROBIO INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), CYTOKINETICS INC (NASDAQ), AGENUS INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), SINOMAB BIO-B (HKEx), MAGENTA THERAPEUTICS INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), STEMLINE THERAPEUTICS INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), ASCLETIS-B (HKEx), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), MACROGENICS INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), MERUS B V (NASDAQ), XBIOTECH INC (NASDAQ), PROGENICS PHARMACEUTICALS INC (NASDAQ), DERMIRA INC (NASDAQ), ESSEX BIO-TECH (HKEx), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), ARDELYX INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), BELLUS HEALTH INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), ANAPTYSBIO INC (NASDAQ), RECRO PHARMA INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), MEDICINOVA INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), PDL BIOPHARMA INC (NASDAQ), COMPUGEN (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), AVID BIOSERVICES INC (NASDAQ), STARPHARMA HOLDINGS LIMITED (ASX), EIGER BIOPHARMACEUTICALS INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), GERON CORP (NASDAQ), KAMADA (NASDAQ), PERSONALIS INC (NASDAQ), TELIX PHARMACEUTIC (ASX), LEE'S PHARM (HKEx), CYTOMX THERAPEUTICS INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), CUE BIOPHARMA INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), NEXT SCIENCE LTD (ASX), PFENEX INC (NYSE American), MANNKIND CORPORATION (NASDAQ), NEUROINSIGHTS NEUROTECH (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), DPHARMA (Bursa), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), XOMA CORP (NASDAQ), CHIASMA INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), ATHERSYS INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), IVERIC BIO INC (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), CABALETTA BIO INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), AFFIMED N V (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), BBI LIFE SCI (HKEx), GALECTIN THERAPEUTICS INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), ARAVIVE INC (NASDAQ), NEUREN PHARMACEUTICALS LTD (ASX), NANTKWEST INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), CHIMERIX INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), NANOVIRICIDES INC (NYSE American), IMV INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), RESAPP HEALTH LIMITED (ASX), LIMINAL BIOSCIENCES INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), UNI-BIO GROUP (HKEx), FENNEC PHARMACEUTICALS INC (NASDAQ), SESEN BIO INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), PALATIN TECHNOLOGIES INC (NYSE American), CYMABAY THERAPEUTICS INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), LINEAGE CELL THERAPEUTICS INC (NYSE American), NOVAVAX INC (NASDAQ), PYC THERAPEUTICS LIMITED (ASX), HARVARD BIOSCIENCE INC (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), 22ND CENTURY GROUP INC (NYSE American), VERASTEM INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), IMUGENE LIMITED (ASX), ADURO BIOTECH INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), INFLARX N V (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), CYNATA THERAPEUTICS LTD (ASX), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), OTONOMY INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), SYNLOGIC INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), ONCOSIL MEDICAL LIMITED (ASX), SELECTA BIOSCIENCES INC (NASDAQ), CEL-SCI CORP (NYSE American), VERMILLION INC (NASDAQ), VACCINEX INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), COHBAR INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), EQUILLIUM INC (NASDAQ), CORREVIO PHARMA CORP (NASDAQ), TREVENA INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), IMMUTEP LTD (ASX), CATALYST BIOSCIENCES INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), NEWLINK GENETICS CORP (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), INMUNE BIO INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), ORTHOCELL LIMITED (ASX), SYNTHETIC BIOLOGICS INC (NYSE American), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), CURIS INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), RESTORBIO INC (NASDAQ), SAVARA INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), ORGENESIS INC (NASDAQ), CT ENTERPRISE (HKEx), PORT (SET), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), ARMATA PHARMACEUTICALS INC (NYSE American), ALIMERA SCIENCES INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), BIONOMICS LTD (ASX), SUNESIS PHARMACEUTICALS INC (NASDAQ), BIOSINO BIO-TEC (HKEx), ACTINOGEN MEDICAL LTD (ASX), DIAMEDICA THERAPEUTICS INC (NASDAQ), EVOGENE LTD (NASDAQ), ISORAY INC (NYSE American), KAZIA THERAPEUTICS LIMITED (ASX), OUTLOOK THERAPEUTICS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), INVEX THERAPEUTICS LTD NPV (ASX), ZAFGEN INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), FIBROCELL SCIENCE INC (NASDAQ), REGENT PACIFIC (HKEx), SEELOS THERAPEUTICS INC (NASDAQ), NEON THERAPEUTICS INC (NASDAQ), NOVITA HEALTHCARE LTD (ASX), APTEVO THERAPEUTICS INC (NASDAQ), PRESCIENT THERAPEUTICS LIMITED (ASX), ORAGENICS INC (NYSE American), BIOCARDIA INC (NASDAQ), INNOVATE BIOPHARMACEUTICALS INC (NASDAQ), MEMPHASYS LTD (ASX), CONTRAFECT CORP (NASDAQ), IBIO INC (NYSE American), BIOTRON (ASX), SOLIGENIX INC (NASDAQ), RHINOMED LIMITED (ASX), BIO-PATH HOLDINGS INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), EXTRAWELL PHAR (HKEx), INDIA GLOBALIZATION CAPITAL INC (NYSE American), UNUM THERAPEUTICS INC (NASDAQ), ACTINIUM PHARMACEUTICALS INC (NYSE American), AZURRX BIOPHARMA INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), PROTEOMICS INTL LABORATORIES LTD (ASX), ADVAXIS INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), ANTEOTECH LIMITED (ASX), AEVI GENOMIC MEDIC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), REGENEUS LTD (ASX), CELLECTAR BIOSCIENCES INC (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), IMMURON LIMITED (ASX), PULMATRIX INCORPORATED (NASDAQ), ATYR PHARMA INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), SENESTECH INC (NASDAQ), CELLMID LIMITED (ASX), PATRYS LIMITED (ASX), DARE BIOSCIENCE INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), TOCAGEN INC (NASDAQ), VAXART INC (NASDAQ), PRECIPIO INC (NASDAQ), CONTANGO ASSET MANAGEMENT LIMITED (ASX), OCUGEN INC (NASDAQ), Suntar Eco-City^ (SGX), ALTERITY THERAPEUTICS LIMITED (ASX), MIDATECH PHARMA PLC SPON ADS EACH REP 20 ORD SHS(R/S) (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), GENETIC TECHNOLOGIES (ASX), BIOCEPT INC (NASDAQ), SOPHIRIS BIO INC (NASDAQ), CONATUS PHARMACEUTICALS INC (NASDAQ), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), HOLISTA COLLTECH LIMITED (ASX), ADALTA LTD (ASX), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), TROVAGENE INC (NASDAQ), CCP TECHNOLOGIES LTD (ASX), CYCLACEL PHARMA IN (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), NOVABAY PHARMACEUTICALS INC (NYSE American), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), BENITEC BIOPHARMA LTD (ASX), ARCA BIOPHARMA INC (NASDAQ), MEGASUN (Bursa), TRILLIUM THERAPEUTICS INC (NASDAQ), MEDIBIO LIMITED (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), BENITEC BIOPHARMA LTD SPON ADS EA REPR 200 ORD SHS(POST SPLIT) (NASDAQ), MGRC (Bursa), HAO WEN HLDGS (HKEx), XENETIC BIOSCIENCES INC (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), ANATARA LIFESCIENCES LTD (ASX), TBG DIAGNOSTICS LTD (ASX), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), LIVING CELL TECHNOLOGIES (ASX), BIOXYNE LIMITED (ASX), OPGEN INC (NASDAQ), SIENNA CANCER DIAGNOSTICS LTD (ASX), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), PROTEON THERAPEUTICS INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), QT Vascular (SGX), DIFFUSION PHARMACEUTICALS INC (NASDAQ), AVECHO BIOTECHNOLOGY LTD (ASX), SENECA BIOPHARMA INC (NASDAQ), AIM IMMUNOTECH INC (NYSE American), AURIS MEDICAL HOLDING LTD (NASDAQ), SPHERIX INC (NASDAQ), BPH ENERGY LIMITED (ASX), ONCONOVA THERAPEUTICS INC (NASDAQ), AMPLIA THERAPEUTICS LTD (ASX), NANOLLOSE LTD (ASX), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), FACTOR THERAPEUTICS LIMITED (ASX), MOTIF BIO PLC ADR EACH REPR 20 SHS SPON (NASDAQ)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --1.030
-5.78 %
10 Days -+2.690
+19.09 %
20 Days -+10.920
+186.35 %
Medium Term Return 3 Months -+9.270
+123.44 %
6 Months -+7.010
+71.75 %
1 Year --1.400
-7.70 %
Long Term Return 2 Years -+4.710
+39.02 %
3 Years -+5.490
+48.63 %
Annualised Return Annualised --
+14.12 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 4.140 - 26.020 Change From 1 Year Low +12.640 % Change From 1 Year Low (%) +305.31
Change From 1 Year High -9.240 % Change From 1 Year High (%) -35.51
2 Years Range 4.140 - 27.450 Change From 2 Years Low +12.640 % Change From 2 Years Low (%) +305.31
Change From 2 Years High -10.670 % Change From 2 Years High (%) -38.87
5 Years Range 4.140 - 27.450 Change From 5 Years Low +12.640 % Change From 5 Years Low (%) +305.31
Change From 5 Years High -10.670 % Change From 5 Years High (%) -38.87
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Myovant Sciences, Inc. is a clinical-stage biopharmaceutical company. It focuses on developing and commercializing therapies for the treatment of women's health and endocrine diseases. The company's product includes relugolix, which is an oral, once-daily and small molecule that acts as a GnRH receptor antagonist. It also develops MVT-602 a kisspeptin agonist for the treatment of female infertility. The company was founded on February 2, 2016 and is headquartered in London, the United Kingdom.

Historical Price Data

Date Open High Low Close Volume VWAP
05 Dec 2019 17.520 17.920 16.630 16.780 1,690,598 -
04 Dec 2019 18.400 18.690 16.550 17.320 3,799,980 -
03 Dec 2019 18.650 19.580 18.320 18.620 2,593,210 -
02 Dec 2019 18.450 19.330 17.530 19.210 3,867,224 -
29 Nov 2019 18.410 19.400 17.450 17.810 4,029,101 -
27 Nov 2019 14.950 17.480 14.850 17.240 5,221,577 -
26 Nov 2019 15.010 15.420 14.400 15.020 2,171,306 -
25 Nov 2019 14.580 15.460 14.200 15.040 4,724,226 -
22 Nov 2019 12.360 14.400 12.120 14.090 5,752,501 -
21 Nov 2019 12.250 12.700 11.280 12.430 4,456,497 -
20 Nov 2019 13.550 14.600 12.150 12.850 13,817,960 -
19 Nov 2019 13.370 17.170 10.370 12.920 72,510,520 -
18 Nov 2019 6.230 6.340 6.010 6.060 231,219 -
15 Nov 2019 6.050 6.210 5.860 6.170 299,106 -
14 Nov 2019 6.080 6.260 5.740 6.010 408,692 -
13 Nov 2019 5.770 6.430 5.680 6.100 551,440 -
12 Nov 2019 5.390 6.000 5.390 5.850 457,427 -
11 Nov 2019 5.900 5.938 5.470 5.530 201,519 -
08 Nov 2019 5.440 5.910 5.410 5.860 369,897 -
07 Nov 2019 5.610 5.889 5.360 5.450 257,591 -
06 Nov 2019 5.710 5.900 5.560 5.630 244,408 -
05 Nov 2019 5.760 5.760 5.520 5.710 259,138 -
Summary
Current 2 Weeks
(21 Nov 2019 to 05 Dec 2019)
12.250 19.580 11.280 16.780 38,306,220 -
Previous 2 Weeks
(07 Nov 2019 to 20 Nov 2019)
5.610 19.580 5.360 12.850 89,105,371 -
4 Weeks from
(10 Oct 2019 to 06 Nov 2019)
4.800 19.580 4.730 5.630 9,765,551 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.